Phage Therapy: Navigating the Mechanisms, Benefits, and Challenges in the Fight Against Multidrug-Resistant Infections
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Background
The emergence of multidrug-resistant (MDR) infections represents one of the most critical challenges faced by contemporary medical practice. The World Health Organization (WHO) has identified antibiotic resistance as a significant threat to global health, with MDR bacteria leading to increased morbidity, mortality, and healthcare costs [1] .
Objective (PICOS)
This review examines (P) MDR infection patients receiving (I) short-term (0-14 day) phage therapy versus (C) long-term/antibiotic treatments, assessing (O) efficacy (eradication rates) and safety (adverse events) through (S) clinical trial/case study analysis.
Primary & Secondary Outcome Measures
Efficacy (bacterial eradication) and safety (adverse events) of 0–14 day phage therapy, compared to conventional antibiotics or longer phage regimens.
Intervention
Application of bacteriophages (viruses that infect and lyse bacteria) as targeted antimicrobial agents.
Methods
A comprehensive review of clinical trials, case studies, and experimental models from peer-reviewed literature.
Results
Phage therapy demonstrates high bacterial specificity, adaptability to resistance, and synergistic effects with antibiotics.
Article Summary
While phage therapy offers a promising alternative to antibiotics, its clinical integration faces regulatory, logistical, and safety challenges.
Strengths and limitations of this study
The strengths include detailed analysis of phage mechanisms, clinical applications, and therapeutic potential. The limitations are limited large-scale randomized controlled trials (RCTs) and standardized treatment protocols & last is This review was not registered in PROSPERO.
Conclusion
Phage therapy holds transformative potential in combating MDR infections but requires further research, regulatory standardization, and clinical validation.
